Gland Pharma dropped 3.37% to Rs 2038.30 after the company’s consolidated net profit declined 25.94% to Rs 143.76 crore in Q1 FY25 as compared with Rs 194.10 crore in Q1 FY24.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
